Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.
The company’s proprietary Convergence Platform integrates technologies and insights from world-renowned scientific leaders in the fields of glycoscience and human immunology to create a novel approach to treating cancer. By targeting multiple immune cell types, Glyco-Immune Checkpoint inhibitors will tackle resistance to first-generation immuno-oncology agents, and make possible a wider range of rational combination therapies to treat cancer. While Palleon is focused primarily on oncology, the Convergence Platform is applicable to other therapeutic areas including infectious diseases, neurodegeneration, inflammation, and fibrosis.
The company is advancing its pipeline and development programs with a $47.6 million Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures.
Location: United States, Massachusetts, Waltham
Member count: 11-50
Total raised: $147.6M
Founded date: 2016
Investors 1
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
17.09.2020 | Series B | $100M | - | finsmes.co... |
04.10.2017 | Series A | $47.6M | - | citybizlis... |
Mentions in press and media 11
Date | Title | Description | Category | Author | Source |
28.06.2022 | Palleon Ph... | Palleon and Henlius to co-deve... | - | - | en.prnasia... |
04.12.2020 | GSK vet An... | Antony Blanc → Enthused abou... | - | Alex Hoffm... | endpts.com... |
17.09.2020 | Palleon Ph... | Palleon Pharmaceuticals, a Wal... | USA | - | finsmes.co... |
17.09.2020 | Palleon Ph... | WALTHAM, Mass.--(BUSINESS WIRE... | - | - | citybizlis... |
17.09.2020 | Jim Brode... | When Jim Broderick launched ... | Financing | Nicole DeF... | endpts.com... |
17.09.2020 | Palleon Ph... | WALTHAM, MA, Palleon Pharmac... | - | - | vcnewsdail... |
06.10.2017 | Term Sheet... | DAYS OF CHANGE Happy Friday, ... | - | - | fortune.co... |
04.10.2017 | Startup Pa... | The immuno-oncology sector has... | Biotech | - | fiercebiot... |
04.10.2017 | Palleon Ph... | WALTHAM, Mass.--(BUSINESS WIRE... | - | - | citybizlis... |
04.10.2017 | Palleon Ph... | Palleon Pharmaceuticals, a Wal... | USA | - | finsmes.co... |
Show more